Accelerating Research at the Molecular Level
March 01, 2013
JWCI researchers embrace a new cell-sorting machine.
Translational medicine. That’s the term used for moving knowledge attained in research laboratories to patients’ bedsides as rapidly as possible. The potential to turn pioneering therapies into life-saving treatments is on full display at the John Wayne Cancer Institute Molecular Oncology Laboratory. Researchers are studying cancer at its most basic level: the molecules that cause tumors to behave in specific ways.
The research is augmented by a technology called fluorescenceactivated cell scanning (FACS). A machine separates cells that are phenotypically different from each other. It identifies how many cells have expressed key proteins and how much these proteins have been expressed – details that help unravel the mysteries of cancer.
JWCI will soon replace itscurrent 11-year-old cell-sorting machine with a new FACS machine. The upgrade in technology will help the Institute recruit top scientists and continue to reap the benefits of translational medicine. JWCI wishes to thank the generosity of John Wayne Cancer Institute Auxiliary, Roy E. Coats Memorial Fund/Laura Coats and Thom Schulz, Mary Ann and Marvin Weiss, and Maria Lim McClay for their contributions toward this important acquisition.